Navigation Links
Patient Advocate Foundation Announces Significant Operational, Technology Enhancements to Co-Pay Relief (CPR) Program
Date:7/11/2011

HAMPTON, Va., July 11, 2011 /PRNewswire-USNewswire/ -- Patient Advocate Foundation (PAF), a national non-profit organization that seeks to safeguard patients through effective mediation assuring access to care, maintenance of employment and preservation of their financial stability relative to their diagnosis of life-threatening or debilitating diseases, is pleased to announce improvements to its Co-Pay Relief (CPR) Program beginning on August 1, 2011 that will allow more patients to be served through a new operational model and will provide enhanced service to both providers and patients through new technology tools.

PAF's Co-Pay Relief Program provides direct financial support for pharmaceutical co-payments to insured patients, including Medicare Part D beneficiaries, who financially and medically qualify and are being treated for breast, lung, prostate, kidney, colon, non squamous non small cell lung and non muscle invasive bladder  cancers, malignant brain tumor, cutaneous t-cell lymphoma sarcoma,  multiple myeloma, myelodysplastic syndrome (and other pre-leukemia diseases), osteoporosis, pain, hepatitis C, rheumatoid arthritis, selected autoimmune disorders, CIA/CIN and patients undergoing hormone suppression therapy. Since the program's inception in April 2004, CPR distributed more than $120 million in assistance to more than 46,000 patients who were unable to afford their pharmaceutical co-payments.

CPR donations will now be released in total into each disease silo immediately upon receipt, rather than dividing contributions across a twelve month period. CPR will accept all qualified new and renewal applications on a first come, first serve basis with no limit imposed on the number of approvals issued monthly. CPR will also accept and process all expenditures on a first come, first serve basis until the available funds in the entire silo are exhausted. Eligible expenditures may be submitted by patients, providers and/or pharmacist
'/>"/>

SOURCE Patient Advocate Foundation
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Dendreon Announces Publication of Phase 1 Study Highlighting Immunologic and Clinical Activity of Lapuleucel-T (Neuvenge(R)) in Advanced Breast Cancer Patients
2. Cephalon Announces Positive Results from a Pivotal Study of FENTORA in Opioid-tolerant Patients with Non-cancer Breakthrough Pain
3. Millennium Initiates Clinical Trial to EVOLVE the Treatment of Patients with Newly Diagnosed Multiple Myeloma
4. Allos Therapeutics Initiates Study of PDX in Patients with Cutaneous T-Cell Lymphoma
5. Vion Pharmaceuticals Completes Accrual of 85 Patients to its Pivotal Phase II Trial of Cloretazine(R) (VNP40101M) in Elderly AML
6. Sixty-One Percent of Newly Diagnosed Parkinsons Disease Patients Do Not Receive Any Drug Treatment in the First Year of Diagnosis
7. TaiGen Biotechnology Successfully Completes Patient Recruitment for Phase II Trial of Nemonoxacin for Treatment of Adult Community Acquired Pneumonia (CAP)
8. Callisto Pharmaceuticals Opens Additional Sites for Phase II Clinical Trial of Atiprimod in Advanced Carcinoid Cancer Patients
9. TorreyPines Therapeutics Completes Patient Enrollment in Phase IIb Clinical Trial of Tezampanel for the Treatment of Acute Migraine Headache
10. Many Heart Attack Patients Dont Get Best Emergency Treatment
11. Video: Landmark Study in The Lancet: Patients Treated With Betaseron(R) After First MS Attack Experienced Significant Delay in MS Progression
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/18/2014)... September 18, 2014 According ... (Surface & Intravascular Systems- Warming & Cooling), Application ... (Surgeon & Anesthesiologist, Nursing & Paramedical Staff) - ... MarketsandMarkets, this report studies the global Temperature Management Market ... The market is expected to reach $2.5 Billion ...
(Date:9/18/2014)... SAN ANTONIO, Texas , Sept. 18, 2014  Casen ... vessels, skin and muscles to harden.  His case is one ... (GVM) in the world.  The only hospital in ... few in the world, offering treatment with the dual wave-length ... in San Antonio . Using a laser ...
(Date:9/18/2014)... , Sept. 18, 2014 Research ... "China PTCA Balloon Market Investment Report, 2014-2016" ... as a indispensable medical device in percutaneous coronary intervention ... stent, but also as a device for pre-/post-stent dilatations. ... related to that of PCI. As national ...
Breaking Medicine Technology:Temperature Management Market Worth $2.5 Billion by 2019 2Temperature Management Market Worth $2.5 Billion by 2019 3Temperature Management Market Worth $2.5 Billion by 2019 4Methodist Children's Hospital In San Antonio, TX Only Hospital In The U.S. Treating Rare Vascular Condition With Dual Wave-Length Laser 2China PTCA Balloon Market Investment Report, 2014-2016 2China PTCA Balloon Market Investment Report, 2014-2016 3
... Medical Systems, a global developer of high-end ultrasound systems, ... number of clinical applications and ranked first or second ... KLAS  "Ultrasound 2011: Innovation on the Move" report. ... monitoring and reporting the performance of information technology and ...
... Suneva Medical, a privately-held aesthetic medical device ... aesthetics injectable business with approval from Health Canada ... dermal filler for nasolabial folds or smile line ... long-lasting treatment, Bellafill provides physicians the opportunity to ...
Cached Medicine Technology:ZONARE Scores in Clinical Applications, Performance and Customer Support & Service in KLAS 2011 Ultrasound Report 2ZONARE Scores in Clinical Applications, Performance and Customer Support & Service in KLAS 2011 Ultrasound Report 3Suneva Medical Announces Canadian Approval of Bellafill™ 2
(Date:9/18/2014)... (PRWEB) September 18, 2014 October is ... Domestic Violence Awareness Month. And the Centers for Disease ... a scary story. , According to the CDC survey, ... of men in the U.S. experience some form of ... relationship. The same survey shows that about half of ...
(Date:9/18/2014)... 18, 2014 According to ... Market Research "Pipeline Analysis of Hospital Acquired ... Amikacin Inhale, Plazomicin, and Synflorix) - Global ... Forecast 2014 - 2020," six phase III ... 3.8 billion by 2020. , Browse the ...
(Date:9/18/2014)... September 18, 2014 The Spartan race ... Period. With course lengths of 3+miles (Sprint), 8+miles, ... mud, water, and signature obstacles designed to help participants ... enjoy participating in a Spartan Race and the feeling ... Spartan races attract and accept people of all ages, ...
(Date:9/18/2014)... (PRWEB) September 18, 2014 ItsHot.com, a ... is now offering a 65-80% discount on its attractive ... whopping 71% off on its 14K Gold Pave Diamond ... band can now be bought for just $775. The ... , Talking about this diamond band, a representative stated, ...
(Date:9/18/2014)... With the arrival of subsequent-entry biologics (SEBs) set to alter ... to educate stakeholders on their potential impact. The bottom line: ... patients must be well informed when speaking to their healthcare ... an infographic and an expert video explaining the impact of ... Arthritis Society’s position paper on SEBs. ,“This new ...
Breaking Medicine News(10 mins):Health News:What you should know about domestic violence 2Health News:What you should know about domestic violence 3Health News:What you should know about domestic violence 4Health News:What you should know about domestic violence 5Health News:Pipeline Analysis of Hospital Acquired Pneumonia Drugs Market Reveals Six Potential Late Stage Candidates and Ten Late Stage Candidates: Transparency Market Research 2Health News:Pipeline Analysis of Hospital Acquired Pneumonia Drugs Market Reveals Six Potential Late Stage Candidates and Ten Late Stage Candidates: Transparency Market Research 3Health News:Pipeline Analysis of Hospital Acquired Pneumonia Drugs Market Reveals Six Potential Late Stage Candidates and Ten Late Stage Candidates: Transparency Market Research 4Health News:A Marine Corps Combat Veteran Teams Up with Spartan Races to Ease the Pain and Speed Up Recovery of Spartan Race Warriors with Topricin Pain Relief and Healing Creams 2Health News:A Marine Corps Combat Veteran Teams Up with Spartan Races to Ease the Pain and Speed Up Recovery of Spartan Race Warriors with Topricin Pain Relief and Healing Creams 3Health News:A Marine Corps Combat Veteran Teams Up with Spartan Races to Ease the Pain and Speed Up Recovery of Spartan Race Warriors with Topricin Pain Relief and Healing Creams 4Health News:ItsHot.com Now Offering 65-80% Discount on its Striking Collection of Diamond Wedding Bands 2Health News:Subsequent-entry biologics set to alter the arthritis treatment landscape 2
... , ATLANTA, Aug. 6 ... the launch of an Atlanta-based program aimed at improving ... Emory University,s Latino Diabetes Education Program and the Johnson ... diabetes education in Hispanic and African American populations and ...
... , , MOUNTAIN ... MAPP ) announced today the pricing of its previously announced public ... offering price of $9.70 per share. Net proceeds, after estimated underwriting ... MAP Pharmaceuticals has granted the underwriters of the offering a ...
... , , , ... Inc. (OTC Bulletin Board: CCEL), one of the largest and most ... proliferative ability of stem cells found in menstrual blood (known as ... Dalian, China. Data from an in vitro study show that MenSCs ...
... Puerto Ricans, Mexicans, study finds , WEDNESDAY, Aug. 5 (HealthDay ... the good life comes at a price: A new study ... , Living the American lifestyle is probably to blame, say ... , Of three Hispanic subgroups they studied -- Puerto Ricans, ...
... , ST. LOUIS, Aug. 6 ... improvement and cost savings results of the IMI program at ... Association (AHA) Leadership Summit. Kirk Mathews, CEO of IMI, and ... average three-month-trend results of $1,500 Cost-per-Case reduction as well as ...
... TAMPA, Fla., Aug. 6 Gold Standard/Elsevier ... launch of three MedCounselor consumer drug information modules for pharmacies ... how to take medications safely, assists in identifying unknown tablets ... are indispensable in helping to increase consumer compliance to their ...
Cached Medicine News:Health News:AADE, Emory University and Johnson & Johnson Diabetes Institute Partner to Educate and Improve Access to Care for Atlanta-area Minorities with Diabetes 2Health News:AADE, Emory University and Johnson & Johnson Diabetes Institute Partner to Educate and Improve Access to Care for Atlanta-area Minorities with Diabetes 3Health News:AADE, Emory University and Johnson & Johnson Diabetes Institute Partner to Educate and Improve Access to Care for Atlanta-area Minorities with Diabetes 4Health News:MAP Pharmaceuticals, Inc. Announces Pricing of Public Offering of Common Stock 2Health News:MAP Pharmaceuticals, Inc. Announces Pricing of Public Offering of Common Stock 3Health News:Cryo-Cell to Present Novel Adult Stem Cell Research During 2009 China Medical Biotech Forum 2Health News:Cryo-Cell to Present Novel Adult Stem Cell Research During 2009 China Medical Biotech Forum 3Health News:Cryo-Cell to Present Novel Adult Stem Cell Research During 2009 China Medical Biotech Forum 4Health News:Living in U.S. May Raise Hispanics' Cancer Risk 2Health News:Living in U.S. May Raise Hispanics' Cancer Risk 3Health News:Inpatient Management, Inc. and Reid Hospital Achieve Performance Improvement and Cost Savings 2Health News:Gold Standard/Elsevier Launches MedCounselor Consumer Drug Information Modules 2Health News:Gold Standard/Elsevier Launches MedCounselor Consumer Drug Information Modules 3
Titanium. Straight shafts with 6 mm platform and Pierse tips. Flat serrated handle with dull finish....
Delicate strong curved serrated tips. Serrated handle with dull finish....
1 x 2 teeth, cross serrated 5 mm 60 degree angled platform. Round knurled handle with polished finish....
Two 2.75 mm long tips separated 1 mm with 1 x 2 teeth. Serrated handle with dull finish....
Medicine Products: